The Nifty is down 16.16% from its record high of 12,430.50 hit on 20 January 2020.
Global stock markets witnessed a selloff amid a plunge in crude oil prices after OPEC failed to strike a deal with its allies on production cuts, adding to volatility already brought about by fears surrounding the coronavirus spread. Oil price crash is a worrying sign for the health of the world economy. Investor sentiments also turned weak amid the ongoing crisis at Yes Bank, which can impact the financial sector as a whole.
Meanwhile, the number of coronavirus cases in India rose to 43 on Monday with four people, including a three-year-old child in Kerala who had returned from Italy, testing positive for the disease, Health Ministry officials reportedly said.
In the broader market, the S&P BSE Mid-Cap index was down 4.64% and the S&P BSE Small-Cap index was down 4.38%. The fall in both these indices was lesser than the fall in the Sensex.
Sellers outpaced buyers. On the BSE, 277 shares rose and 2178 shares fell. A total of 167 shares were unchanged. In Nifty 50 index, 4 stocks advanced while 46 stocks declined.
Numbers to Track:
More From This Section
In the foreign exchange market, the partially convertible rupee was trading at 74.0825, lower than its previous closing of 73.87.
The yield on 10-year benchmark federal paper rose to 6.043% at 14:21 IST compared with 6.185% in the previous trading session.
In the commodities market, Brent crude for May 2020 settlement was down $9.26 to $36.01 a barrel. The contract fell $4.72 or 9.44% to settle at $45.27 a barrel in the previous trading session.
MCX Gold futures for 3 April 2020 settlement rose 0.03% to Rs 44,170.
Buzzing Index:
The Nifty Pharma index fell 3.17% to 7,763.80, extending decline for second day. The index has lost 4.69% in the past two sessions.
Wockhardt (down 8.97%), Aurobindo Pharma (down 6.76%), Cadila Healthcare (down 5.92%), Piramal Enterprises (down 5.25%), Alkem Laboratories (down 4.62%), Glenmark Pharmaceuticals (down 4.53%), Strides Shasun (down 3.47%), Dr Reddy's Laboratories (down 3.04%), Divi's Laboratories (down 3%), Sun Pharmaceutical Industries (down 2.27%), GlaxoSmithKline Pharmaceuticals (down 2.18%), Lupin (down 1.66%) and Cipla (down 1.41%) declined.
Divi's Laboratories fell 2.29% to Rs 2189. "This is to inform that the company has commenced commercial production effective from 9 March 2020 from DCV-SEZ unit of the company at Chippada Village, Bheemunipatnam Mandal, Visakhapatnam", the drug maker said in a statement.
SMS Pharmaceuticals slipped 0.27% to Rs 36.85. The United States Food and Drug Administration (USFDA) conducted a regulatory inspection of the testing facility Central Laboratory Analytical Services from 2 to 6 March 2020, the company said in an exchange filing. The audit resulted in zero observation, it said.
Hikal slumped 9.45% to Rs 104.90. The Maharashtra Pollution Control Board (MPCB) asked the drug ingredient manufacturer to close its Mahad unit. The company received the notice of closure from MPCB following a complaint by the locals in Taloja. The complaint said a tanker of an authorized transporter, carrying byproduct of Hikal, was found near Kasadi river in Taloja. This material was on the way for further processing to a MPCB-approved manufacturer located in MIDC Dhule. The company has filed a writ petition in the Bombay High Court for a stay on the order. Some its operations at Mahad could be affected until the matter was resolved, it added.
Powered by Capital Market - Live News